New England Journal of Medicine Archives

Covid-19 Vaccine Frequently Asked Questions

posted 1 day

Mashup Score: 5

New England Journal of Medicine (NEJM) - Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging...

Richard Schilsky

Great FAQ on COVID vaccination. https://t.co/HZnc1TL5IH

Covid-19 Vaccine Frequently Asked Questions

posted 1 day

Mashup Score: 5

New England Journal of Medicine (NEJM) - Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging...

Harvard Medical School

Paul Sax, an HMS professor and infectious disease specialist, provides answers to clinicians’ questions about COVID-19 vaccination and to the questions and concerns patients will raise https://t.co/W2pF5qvyOv via @NEJM https://t.co/W2pF5qvyOv

Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 | NEJM

posted 22 hours

Mashup Score: 4

New England Journal of Medicine (NEJM) - Editorial from The New England Journal of Medicine — Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control...

Monica Gandhi MD, MPH

Asymptomatic spread is actually the Achilles heel of COVID-19 prevention which is why masks are recommended. But that is because people were not immune as they will be after vaccine; immunity takes this from bad virus to nothing virus (95% efficacy) https://t.co/6oDxIFsrbu

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease | NEJM

posted 2 days

Mashup Score: 2

New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Sotagliflozin in Patients with Diabetes and Chronic Kidney...

Harriette Van Spall, MD MPH

Delighted to discuss the #SCORED RCT (published in @NEJM this week) with @DLBHATTMD In #DM + #CKD, #sotagliflozin: ⬇️risk of the composite CV ☠️ & worsening #HF (HR 0.74; 95 CI 0.63-0.88) ⬆️adverse events 📄 https://t.co/Q8VgKRMG9B 🎬 https://t.co/Q8VgKRMG9B @HeartOTXHeartMD https://t.co/Q8VgKRMG9B https://t.co/Q8VgKRMG9B

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation | NEJM

posted 2 days

New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Early or Delayed Cardioversion in Recent-Onset Atrial...

Med Peds Hospitalist

Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation | NEJM https://t.co/S2Dhuw6iDZ

Covid-19 Vaccine Frequently Asked Questions

posted 1 day

New England Journal of Medicine (NEJM) - Paul E. Sax, M.D. Paul Sax, M.D., a Professor of Medicine at Harvard Medical School and an infectious disease specialist, provides concise and engaging...

Vivek Subbiah, MD

From ⁦@NEJM⁩ — Covid-19 Vaccine Frequently Asked Questions (FAQ) https://t.co/LEpdBmOoZD

A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops | NEJM

posted 20 hours

New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — A Cluster-Randomized Trial of Blood-Pressure Reduction in Black...

Tim Brown

A reminder that we already have the knowledge to address disparities in healthcare delivery. Whether or not we apply this to the covid vaccine is up to us. https://t.co/t3ExLVGQio

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure | NEJM

posted 6 hours

New England Journal of Medicine (NEJM) - Original Article from The New England Journal of Medicine — Sotagliflozin in Patients with Diabetes and Recent Worsening Heart...

David A. Cohen

More SGLT2i love. Sotagliflozin decreases cardiovascular deaths + heart failure hospitalizations in patients with decompensated HF & #diabetes. And guess what, no increase risk of UTI. #EndoTwitter #CardioTwitter https://t.co/o8tCIwHLRi https://t.co/o8tCIwHLRi